Posted by
Biosimilars in 2020: All eyes on how Indian pharmas cash in on investments after betting on foreign markets

Biosimilars in 2020: All eyes on how Indian pharmas cash in on investments after betting on foreign markets

While over 50 different biosimilars already exist in the Indian market, the big money lies launching these drugs in Europe and the United States It has been more than a decade since Indian pharmaceutical companies began looking at the biosimilar opportunity. It is not an easy space to be in and quite unlike their traditional […]